Gemzar study
- Conditions
- Cancer
- Registration Number
- PACTR201510001143243
- Lead Sponsor
- AMPATH Oncology Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Histologically confirmed Kaposi's sarcoma
Documented HIV positive state
Documented CD4 cell count
Signed informed consent form
Stage T0 should have taken ARVs for at least 8 weeks
Age over 18 years
Adequate hematologic function i.e neutrophil count more than 1000/microliter of bllod,plateles more than 75000 and HB more tha 10grams
Creatinine level less tha 200mocrograms per ml of blood
ECOG score less than 2
Negative pregnancy test with dual contraception for women of reproductive age
Previous treatment with chemotherapy or radiotherapy
Unmeasurable KS lesions
Concurrent febrile illneses
Concurrent malignancy
Allergic reaction to any of the study drugs
Breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method